Background Unprecedented public health actions restricting movement and non-COVID related health services are likely to have affected abortion care during the pandemic in Europe. In the absence of a common approach to ensure access to this essential health service, we sought to describe the variability of abortion policies during the outbreak in Europe in order to identify strategies that improve availability and access to abortion in times of public health crises. Methods We collected information from 46 countries/regions: 31 for which country-experts completed a survey and 15 for which we conducted a desk review. We describe abortion regulations and changes to regulations and practice during the pandemic. Results During COVID-19, abortions were banned in six countries and suspended in one. Surgical abortion was less available due to COVID-19 in 12 countries/regions and services were not available or delayed for women with COVID-19 symptoms in eleven. No country expanded its gestational limit for abortion. Changes during COVID-19, mostly designed to reduce in-person consultations, occurred in 13 countries/regions. Altogether eight countries/regions provided home medical abortion with mifepristone and misoprostol beyond 9 weeks (from 9 weeks+6 days to 11 weeks+6 days) and 13 countries/regions up to 9 weeks (in some instances only misoprostol could be taken at home). Only six countries/regions offered abortion by telemedicine. Conclusions The lack of a unified policy response to COVID-19 restrictions has widened inequities in abortion access in Europe, but some innovations including telemedicine deployed during the outbreak could serve as a catalyst to ensure continuity and equity of abortion care. All data relevant to the study are included in the article or uploaded as supplementary information. The data collected for this study are displayed in the tables.

中文翻译：

---

COVID-19 时代欧洲的堕胎监管：一系列政策反应

背景 在欧洲大流行期间，限制行动的前所未有的公共卫生行动和与 COVID 无关的卫生服务可能影响了堕胎护理。在缺乏确保获得这种基本卫生服务的通用方法的情况下，我们试图描述欧洲爆发期间堕胎政策的可变性，以确定在公共卫生危机时期提高堕胎可及性和可及性的策略。方法 我们从 46 个国家/地区收集信息：31 个国家/地区的专家完成了调查，15 个国家/地区进行了案头审查。我们描述了大流行期间的堕胎法规以及法规和实践的变化。结果 在 COVID-19 期间，六个国家禁止堕胎，一个国家暂停堕胎。由于 COVID-19，12 个国家/地区的手术流产较少，11 个国家/地区出现 COVID-19 症状的女性无法获得或延迟提供服务。没有一个国家扩大了堕胎的妊娠限制。COVID-19 期间的变化主要是为了减少面对面的咨询，发生在 13 个国家/地区。共有8个国家/地区提供米非司酮和米索前列醇的家庭药物流产超过9周（从9周+6天到11周+6天）和13个国家/地区长达9周（在某些情况下只能在家服用米索前列醇） ）。只有六个国家/地区提供远程医疗堕胎服务。结论 缺乏对 COVID-19 限制的统一政策回应扩大了欧洲堕胎机会的不平等，但包括在疫情爆发期间部署的远程医疗在内的一些创新可以作为催化剂，确保流产护理的连续性和公平性。与研究相关的所有数据都包含在文章中或作为补充信息上传。为这项研究收集的数据显示在表格中。